Summary
This 8-K filing from Gilead Sciences, Inc. (GILD) on January 28, 2015, details the compensation arrangements for its named executive officers for fiscal year 2014 and the upcoming 2015 fiscal year. The Compensation Committee of the Board of Directors approved 2014 bonus awards and set 2015 base salaries, alongside granting 2015 equity awards, including stock options and performance-based share awards. The executive compensation is tied to both individual performance and the company's achievement of financial and non-financial objectives. Notably, the CEO, John C. Martin, received a significant bonus for 2014 and substantial equity grants for 2015, reflecting his leadership and the company's performance during the period. The equity awards are structured with performance-based tranches tied to total shareholder return and revenue targets.
Key Highlights
- 1Gilead's Compensation Committee approved 2014 bonus awards and 2015 base salaries for named executive officers on January 22, 2015.
- 2CEO John C. Martin received a 2014 bonus of $3,717,365 and a 2015 base salary of $1,737,000.
- 3Significant equity awards for 2015 were granted to executive officers, including stock options and performance share awards with grant-date fair values.
- 4CEO John C. Martin received the largest 2015 equity grants, with a stock option fair value of $5,750,000 and a performance share fair value of $5,750,000.
- 5Performance share awards are structured with tranches tied to Total Shareholder Return (TSR) and revenue targets, similar to the previous year's awards.
- 6Senior Advisor Kevin Young received time-based restricted stock unit awards and stock options valued at $180,000 each.